In today's IBD Screen of the Day, the focus is on global leaders whose stocks are traded in the U.S. Several oil, mining, financial and shipping companies make this list, especially as geopolitical turmoil has increased. Here are two oil stocks and one insurer near buy points.
Hot Stock Is In Its Buy Range
As energy prices soar, so has the company's growth. Full-year EPS is projected at an impressive $8.78 vs. $4.98 in 2021, according to MarketSmith. Strong growth has helped lift Shell's IBD Composite Rating to 98. It shares the No. 8 ranking with Ecopetrol in its industry group.
Netherlands-based Shell will report first-quarter earnings on May 5, with EPS estimated at $1.84 and revenue of $80.4 billion, according to FactSet.
Arch Capital is just shy of a 49.25 entry from a first-stage flat base.
The company is slated to release first-quarter results the afternoon of April 27. The consensus EPS estimate is $1.07 and revenue should come in at $2.81 billion. In its most recently reported quarter, Arch Capital reported a 127% leap in earnings to $1.27 per share. It posted EPS growth of 28%, 2,400% and 155% the prior three quarters. Sales last quarter dipped 3% to $2.31 billion.
Insurer Boasts High EPS And Composite Ratings
The Bermuda-based insurance company's EPS Rating is 93 out of a best-possible 99 and it has a 92 Composite Rating. It ranks No. 8 in the IBD Insurance-Property & Casualty industry group.
It also carries an 89 Relative Strength Rating and a C+ Accumulation/Distribution Rating, which indicates slightly more selling than buying of its shares by mutual funds and other big investors. That rating has improved over the past week.
With thousands of names to choose from, how can you efficiently find the best stocks to buy and watch? Zero in on top growth stocks that fit your criteria with IBD Stock Screener.
Investors can build their own screens from scratch, or start with IBD stock lists like the IBD 50, Sector Leaders, Big Cap 20 and IPO Leaders.
From earnings and sales growth to IPO date, dividend yield, current quarter EPS estimates and more, the screener is a valuable tool.
Follow Michael Molinski on Twitter @IMmolinski